Header Logo

Connection

Natalie Erlich-Malona to Alemtuzumab

Back to Details
This is a "connection" page, showing publications Natalie Erlich-Malona has written about Alemtuzumab.
Natalie Erlich-Malona
Connection Strength
0.178
Alemtuzumab
  1. Erlich-Malona N, Cahill J, Chaudhry S, Martin J, Rizvi S. Cardiac sarcoidosis requiring ICD placement and immune thrombocytopenia following alemtuzumab treatment for multiple sclerosis. Mult Scler Relat Disord. 2021 Jan; 47:102599.
    View in: PubMed
    Score: 0.178
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.